1d
Zacks Investment Research on MSNPharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline UpdateNovo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...
The Nifty Pharma index closed on a negative note on Thursday. Shares of Mankind Pharma Ltd.(up 1.61 per cent), J B Chemicals ...
Sun Pharmaceutical Industries announces acquisition of US-based Checkpoint Therapeutics for up to USD 355 million. The Indian ...
Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results